Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc., a pioneering company in the regenerative medicine sector, is headquartered in the United States. Founded in 2010, Nuo Therapeutics focuses on developing innovative therapies for chronic wounds and other tissue-related conditions, leveraging its expertise in cell-based technologies. The company’s flagship product, Aurix™, is a unique autologous cell therapy that harnesses the body’s own healing capabilities, setting it apart in the competitive landscape of wound care solutions. Nuo Therapeutics has achieved significant milestones, including regulatory approvals and partnerships that enhance its market presence. With a commitment to advancing patient care, Nuo Therapeutics continues to solidify its position as a leader in the regenerative medicine industry, dedicated to improving outcomes for patients worldwide.
DitchCarbon Score
How does Nuo Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nuo Therapeutics, Inc.'s score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Nuo Therapeutics, Inc.'s reported carbon emissions
Nuo Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data may indicate that the company is in the early stages of developing its sustainability strategy or has not yet disclosed its emissions profile. As the industry increasingly prioritises climate action, Nuo Therapeutics may consider establishing measurable targets and initiatives to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nuo Therapeutics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
